$TPST

Tempest Therapeutics Announces Record Date for Warrant Dividends Distribution Following Asset Purchase Agreement

Tempest Therapeutics has announced January 30, 2026, as the record date for the distribution of warrants to purchase its common stock, with the distribution expected on February 3, 2026. This move follows an Asset Purchase Agreement and is contingent on stockholder approval. Each stockholder will receive one warrant per share, exercisable at $18.48 for five years, as part of the company's strategy to advance its cancer treatment pipeline.

Original reporting
Published Jan 21, 2026, 1:57 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 21, 2026, 2:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$TPST
Neutral
medium confidence
Mentioned
$TPST
alphai data visualization · based on Quiver Quantitative
Decision brief

The 30-second read

$TPSTNeutralMed
01

Why it matters

The move could attract investor interest due to the discounted exercise price, but also introduces dilution risk.

02

Market read

The event is primarily relevant to TPST shareholders and biotech investors, with limited broader market impact.

03

What to watch

Market sentiment towards warrant offerings varies; if investor perception turns negative, the stock may decline despite strategic intent.

Timing: High - The record date is set for January 30, 2026, with distribution shortly after, making this a timely event for traders.

Background

Tempest Therapeutics announced a strategic warrant distribution following an asset purchase, aiming to fund its cancer pipeline development.

Company-level read

Ticker impact

$TPSTNeutralMedium confidence
Context

The news pertains directly to Tempest Therapeutics (TPST), highlighting warrant distribution and strategic moves, which could influence stock performance.

Expected impact

Moderate upward movement expected in TPST stock around the warrant distribution date, contingent on investor reception.

Evidence & confidence

The news is specific to TPST's corporate actions, which can influence stock price, but market reaction depends on investor perception and broader market conditions.

Market effects

Potential positive sentiment in biotech and life sciences sectors due to strategic corporate actions.

Limited regional impact; primarily relevant to US markets where TPST is listed.

Minimal; the event is company-specific without immediate global market implications.

Counterpoint

The warrant issuance could lead to dilution, potentially pressuring TPST's stock price downward in the short term.

Key entities

  • Tempest Therapeutics

    Biotech firm focusing on cancer treatments.

Related articles

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.